Centerra Gold Inc.
Centerra Gold Inc. (CG.TO) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Centerra Gold Inc. (CG.TO), featuring income statements, balance sheets, and cash flow data.
Centerra Gold Inc. (CG.TO) Income Statement & Financial Overview
View the income breakdown for Centerra Gold Inc. CG.TO across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $299.50M | $302.39M | $323.93M | $282.31M |
| Cost of Revenue | $222.96M | $222.72M | $216.56M | $190.00M |
| Gross Profit | $76.54M | $79.67M | $107.37M | $114.61M |
| Gross Profit Ratio | $0.26 | $0.26 | $0.33 | $0.41 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $13.11M | $10.19M | $12.87M | $13.13M |
| Operating Expenses | $33.64M | $189.36M | $52.48M | $44.67M |
| Total Costs & Expenses | $256.60M | $412.08M | $269.04M | $234.67M |
| Interest Income | $5.37M | $6.62M | $7.48M | $7.87M |
| Interest Expense | $3.87M | -$6.57M | $3.79M | $3.79M |
| Depreciation & Amortization | $24.87M | $31.83M | $35.14M | $28.97M |
| EBITDA | $84.02M | -$12.34M | $95.57M | $88.19M |
| EBITDA Ratio | $0.28 | -$0.04 | $0.30 | $0.31 |
| Operating Income | $42.90M | -$109.69M | $54.89M | $47.64M |
| Operating Income Ratio | $0.14 | -$0.36 | $0.17 | $0.17 |
| Other Income/Expenses (Net) | $12.38M | $75.38M | $1.76M | $7.79M |
| Income Before Tax | $55.28M | -$34.31M | $56.65M | $55.43M |
| Income Before Tax Ratio | $0.18 | -$0.11 | $0.17 | $0.20 |
| Income Tax Expense | $24.82M | $18.18M | $27.85M | $17.76M |
| Net Income | $30.45M | -$52.50M | $28.79M | $37.67M |
| Net Income Ratio | $0.10 | -$0.17 | $0.09 | $0.13 |
| EPS | $0.15 | -$0.26 | $0.13 | $0.18 |
| Diluted EPS | $0.13 | -$0.25 | $0.13 | $0.18 |
| Weighted Avg Shares Outstanding | $209.33M | $202.55M | $212.31M | $214.95M |
| Weighted Avg Shares Outstanding (Diluted) | $213.72M | $214.15M | $214.15M | $215.02M |
Over the past four quarters, Centerra Gold Inc. demonstrated steady revenue growth, increasing from $282.31M in Q2 2024 to $299.50M in Q1 2025. Operating income reached $42.90M in Q1 2025, maintaining a consistent 14% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $84.02M, reflecting operational efficiency. Net income rose to $30.45M, with EPS at $0.15. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan